These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 12134269

  • 1. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM, Simecka JW.
    J Infect Dis; 2002 Jul 15; 186(2):290-4. PubMed ID: 12134269
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H, Umemura M, Okamoto Y, Yahagi A, Goga H, Harakuni T, Matsuzaki G, Arakawa T.
    Vaccine; 2008 Feb 13; 26(7):924-32. PubMed ID: 18192091
    [Abstract] [Full Text] [Related]

  • 4. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK, Aldwell FE, Beagley KW.
    Vaccine; 2009 Oct 19; 27(44):6217-25. PubMed ID: 19698810
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J, Adamsson J, Harandi AM.
    Scand J Immunol; 2008 May 19; 67(5):431-40. PubMed ID: 18298617
    [Abstract] [Full Text] [Related]

  • 9. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA, Stensson A, Schön K, Lycke N.
    Scand J Immunol; 2006 Feb 19; 63(2):97-105. PubMed ID: 16476008
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.
    Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585
    [Abstract] [Full Text] [Related]

  • 11. Diversity of mucosal immune responses in upper respiratory organs and its application for mucosal vaccine.
    Kurono Y, Miyashita K, Makise T, Nagano H.
    Adv Otorhinolaryngol; 2011 Feb 20; 72():146-8. PubMed ID: 21865715
    [Abstract] [Full Text] [Related]

  • 12. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M, Ikeda Y, Suzumoto M, Yamauchi K, Green BA, Zlotnick G, Billal DS, Shimada J, Fujihara K, Yamanaka N.
    Vaccine; 2005 Jan 26; 23(10):1294-300. PubMed ID: 15652672
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blinded, controlled field trial of two commercially available Mycoplasma bovis bacterin vaccines in veal calves.
    Soehnlen MK, Aydin A, Lengerich EJ, Houser BA, Fenton GD, Lysczek HR, Burns CM, Byler LI, Hattel AL, Wolfgang DR, Jayarao BM.
    Vaccine; 2011 Jul 26; 29(33):5347-54. PubMed ID: 21664397
    [Abstract] [Full Text] [Related]

  • 17. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization.
    Hodge LM, Marinaro M, Jones HP, McGhee JR, Kiyono H, Simecka JW.
    Infect Immun; 2001 Apr 26; 69(4):2328-38. PubMed ID: 11254590
    [Abstract] [Full Text] [Related]

  • 18. Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tract.
    Sanders MT, Deliyannis G, Pearse MJ, McNamara MK, Brown LE.
    Vaccine; 2009 Apr 21; 27(18):2475-82. PubMed ID: 19368789
    [Abstract] [Full Text] [Related]

  • 19. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
    Rodríguez A, Rottenberg M, Tjärnlund A, Fernández C.
    Scand J Immunol; 2006 Mar 21; 63(3):177-83. PubMed ID: 16499570
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.